The medical research services provider collected funding from investors including Cash Capital, an investment arm of CAS which previously backed a series A.
China-based medical research services provider Yunhu Technology has attracted tens of millions of renminbi (RMB10m = $1.5m) in a series A-plus round involving Cash Capital, an investment arm of Chinese Academy of Sciences.
Venture capital firm China Creation Ventures led the round, which was backed by Vision+ Capital, Morningside Venture Capital, and BioTrack Capital.
Founded in 2017, Yunhu Technology offers medical research services through a cloud-based platform facilitating inspections and sampling for more than 1,000 local medical institutions.
The company focuses on three product lines – comprehensive testing products, a health information software engine and a cold-storage logistics network for delivering drug and blood samples.
Yunhu Technology currently has three offices – in Beijing, Shanghai and Hangzhou – and more than 800 employees.
Cash Capital previously put up $1.2m for Yunhu Technology’s $5.5m series A round, where it was joined by BioTrack Capital. Yunhu also…
